controls, even though PPLO were isolated from fifteen of the first group. PPLO isolated from the blood of a woman with puerperal fever, from an empyema wound, and from the genital system of two other women were considered by Stokes (1955) to be the cause of clinical infection in those patients; PPLO antibody appeared in the sera, increased during the *course of the infection, and had decreased 6 months later. Melen and Gotthardson (1955) made similar observations in five cases of salpingo-oophoritis. Pathogenic members of the pleuropneumonia group of organisms also induce antibody formation in animals of various species. Antibodies appear in contagious pleuropneumonia of cattle and in contagious agalactia of sheep; and may be detected by complement-fixation tests as an aid to the diagnosis of those diseases (Campbell and Turner, 1936; Zavagli, 1951) .
Serological tests with an appropriate PPLO antigen offer an obvious way to determine the significance of PPLO in human urethritis. The antigen, however, must be representative of the infecting strains. Accordingly, a survey was made of 56 of the 98 strains isolated by Dr. Klieneberger-Nobel from cases of N.G.U. and other genital infections in man. They fortunately proved to be serologically uniform; and an antigen made from one strain was therefore suitable for the exploration of PPLO antibodies in the human subject.
The instability of suspensions of human PPLO precluded the routine use of agglutination as a means of detecting antibody. The complement-fixation method, which has proved satisfactory in other serological explorations of PPLO infections (Campbell and Turner, 1936; Stokes, 1955;  HuijsmansEvers and Ruys, 1956) , was selected as the method of choice. (b) Ca-Mg Saline.-Normal saline augmented with 1-8 x 10-4 M CaCl,, 0 9 x 10-4 M Mg Cl2 (Mayer, Osler, Bier, and Heidelberger, 1946) , 195 x 10-3 M Boric acid, and 1 36 x 10-4 M sodium borate. This solution was used for diluting reagents and rinsing pipettes. (d) Sheep Cells preserved in Alsever's Fluid.-These were washed three times in normal saline, resuspended in saline, and adjusted to 2-5 per cent. concentration by the haematocrit method of Price and Wilkinson (1947) .
(e) "Haemolytic Immune Body".-This was supplied by the V.D. Reference Laboratory. It was diluted to a concentration of 5MHD on the basis of the titre stated on the bottle.
(f) Sensitized Red Cells.-These were prepared by mixing equal volumes of (d) and (e) 20 min. before use.
(g) Human Sera from Various Sources.-These were inactivated, undiluted, at 56°C. for 30 min.
Methods
(a) Preparation of Antigens.-The growth of human PPLO in liquid media is greatly improved (Edward, 1954) in the presence of the surface of a solid agar medium. Accordingly an agar base, made from 15 ml.
ox-heart infusion agar and 5 ml. human serum, was allowed to set in the bottom of a 500-ml. conical flask; 400 ml. liquid medium (Klieneberger-Nobel, 1958) (c) Preparation of Antisera. PPLO cultures were grown as described above, except that rabbit serum replaced human serum in the medium. The washed organisms were suspended in normal saline at an optical density of 0 2, and rabbits were given the following doses intravenously at 2-day intervals: I ml.; 1 ml.; 2 ml.; 2 ml.; 4 ml.; 6 ml. The rabbits were bled 10 days after the final injection; and the antisera were inactivated at 56°C. for 30 mm. at the lowest dilution tested.
( (e) Complement-Fixation Tests.-These were similarly carried out with dilute sera substituted for saline. All sera were tested in doubling dilutions, the initial range for human sera being from 1/10 to 1/40, and higher dilutions tested when necessary. The serum dilution giving 50 per cent. fixation was taken as the end titre of the serum. Titres are expressed as the reciprocal of the initial serum dilution added to the complement-fixation mixtures. The lowest serum dilution was tested for anticomplementary effect. Negative sera and positive sera of known titre were included in each batch of human sera tested. A control C' titration using i, i, and the full C' dose was made for each antigen. When the C' dose was correct these amounts produced no lysis, 50 per cent. lysis, and complete lysis respectively.
A "blank" antigen was made from 500 ml. uninoculated medium by the method described for the F antigen; it had a faint turbidity. When this preparation was used in the complement-fixation test with human sera diluted 1/10, no complement fixation occurred with either negative or positive sera.
The conditions of complement fixation were varied to test the sensitivity of the reaction. 47 human sera chosen at random were tested by allowing complement fixation to occur both at 37°C. for 1 hr and at 4°C. for 18 hrs, starting at a serum dilution of 1/5 instead of 1/10. Of these only 19 per cent. had a titre of at least 10 (the criterion of positivity in the routine 18-hr test) by the 1-hr test compared with 46 Table I shows that crossing occurred between all strains and all antisera tested; the end titres given by a particular strain with the entire range of antisera provided a means of classifying the strain serologically. Strains of different origin behaved dissimilarly and strains of common origin behaved similarly. For instance, human genital strains could be distinguished serologically from all the human mouth strains and from all the non-human strains tested, whereas all six human mouth strains gave the same titre with mouth strain antiserum and with the other PPLO strains.
A total of 56 PPLO strains isolated from the human urogenital system were examined serologically; each strain was tested against three or more antisera to human genital PPLO and to one or more of the other antisera. The results are summarized in Table II , which shows the number of strains tested with each anti-serum, and the end titres which they gave, homologous-strain titres being given in heavy type. Most of the genital strains crossed to the full titre (or nearly so) with genital-strain anti-serum, There was no significant difference between V.D. clinic patients from the two hospitals (P = 0 3) or between sexes in medical outpatients, blood donors, and children.
As regards the end titres of positive sera (Table IV In patients from V.D. clinics the proportion of positive sera was significantly higher than in other hospital patients (Table III) . Table VI shows a similar trend amongst the V.D. clinic patients themselves; among those men and women who actually had V.D. the proportion of positive sera was significantly higher than among those who had no V.D. history but had attended the clinic because they were merely worried, or were suffering from penile abrasions, warts, etc.
For men with a history of syphilis or yaws the proportion of positive sera was significantly high. A cross-reaction between the PPLO antigen and Wassermann positive sera might account for this, particularly as three of the females with a positive PPLO test proved to be Wassermann-positive infants with congenital syphilis. But this interpretation is not consistent with the results of a series of serological tests for syphilis and yaws made at the time of the PPLO test in a number of the patients. Of 48 patients serologically positive for syphilis or yaws (SY +), only 27 (including two which proved to be falsely positive) were also positive in the PPLO complement-fixation tests with F or B antigen preparations. Moreover, in both positive and negative PPLO groups, there was a good proportion of strongly positive SY + sera. There was no association between SY + and reactivity with either the F or the B antigen alone. Thus, if there is any antigenic relation between Wassermann antigens and the human PPLO, it is clearly minor, and cannot account for the association of the two kinds of positive serological reaction. In this connexion it is noteworthy that PPLO were isolated from the serous fluid of the syphilitic chancre in two of three men examined.
As regards the clinical interpretation of the titres, it is to be noted that the higher PPLO titres occurred in all groups of patients (Table VI) , though the numbers in many groups were too small to be reliable as numerical evidence. Unfortunately it was not possible to examine antibody levels in subsequent specimens of serum, because the majority of patients defaulted in their attendance at the clinic; but in the few positive sera re-tested within a month there was no alteration in titre. One individual, who was free from clinical symptoms, and from whose urine PPLO were isolated on several occasions during 6 weeks, was never sero-positive, either with the routine antigen or with an antigen made from his own strain.
Reiter's Disease.-The sera from nineteen patients with Reiter's disease, and the synovial fluid from two, were examined for PPLO antibodies. All were negative except one which had a titre of 10 with both F and B antigens. Two of the sero-negative patients were re-tested after an attack of urethritis; in one the titre was 20 with the F antigen, and the other remained negative.
Comparisons of Serological Results with Culture Results.-In 26 V.D. clinic patients, ten gynaecological patients, and five others, the serological tests were contemporaneous with cultural tests. (Klieneberger-Nobel, 1958 In five of these cases, the patient's serum was also tested with antigens made from his own strain of PPLO; the result was identical with that obtained with the routine antigen.
As a X2 test showed, the distribution of cases in the four groups does not differ significantly from the distribution to be expected if there was no association whatever between the presence of PPLO in the genital tract and that of PPLO antibody in the blood. However, the group of 41 cases is heterogeneous, as regards patients, type of disease, and stage of disease at which the cultural and serological tests were made. The absence of association does not therefore contradict the strong association between cultural and serological positive results which is evident when the various groups are considered as populations rather than as individuals (see below). Melen and Gotthardson (1955) detected complement-fixing antibodies to PPLO in the absence of cultivable genital PPLO and found that the presence of PPLO in the genital tract was not necessarily followed by the formation of detectable antibodies.
Discussion
There is circumstantial evidence that human genital PPLO are transmitted by sexual intercourse (Dienes and Smith, 1942; Morton, Smith, and Leberman, 1951) . If their presence in the urogenital tract leads to detectable antibodies, then in any group the incidence of antibodies should be related to the probability of infection.
The incidence of antibodies to human genital PPLO was roughly in accordance with the expected frequency of venereal disease in the various groups of subjects tested. In patients with venereal disease the proportion of positive sera was highest; in blood donors and children it was the lowest; and in unconfirmed venereal disease suspects, and gynaecological, medical, and antenatal outpatients the proportions were intermediate, diminishing in that order. It is to be expected that blood donors and children would be relatively free from venereal disease, owing to high standards of hygiene and small opportunity for infection. Amongst the intermediate groups the incidence would be expected to depend on the environment and mores of the population from which they were drawn. Thus Shepard (1954) suggested that different sexual behaviour might account for the different incidence of human genital PPLO found in Negro and white students. Infection, of course, is not wholly the outcome of sexual promiscuity, and it is possible that women suffering from apparently non-venereal gynaecological complaints are in fact infected with PPLO (Gotthardson and Melen, 1953) .
The trend of the serological findings reported here agrees with the results of Klieneberger-Nobel (1959) (Stokes, 1955) and in rats infected with a PPLO causing polyarthritis in rats (Klieneberger-Nobel and Card, unpublished) , it seems likely that the antibodies in human sera are the result of infection, at some time, with human genital PPLO. It is not possible to draw conclusions about the exact role of PPLO in non-gonococcal infections, since there was little opportunity to study antibody levels in patients with recently acquired infections. PPLO antibodies occurred in patients with a history of non-gonococcal genital infection, and in patients with other venereal diseases-a result which is not altogether unexpected in view of the frequency with which PPLO are isolated from the genital tract of patients with gonorrhoea and trichomonal infections (Klieneberger-Nobel, 1959) and even from syphilitic chancres. The relation of PPLO antibody to immunity and to the presence of detectable PPLO in the genital tract is unknown, and a more precise survey of the course of the disease in terms of both serology and culture is needed to establish the significance of a positive serum reaction in an individual patient.
The human genital PPLO strains fell into one serological group; Nicol and Edward (1953) found only one serologically distinctive strain in 91 strains examined. But Huijsmans-Evers and Ruys (1956) found three serological groups which could also be distinguished by cultivation and biochemical characteristics; the majority of their strains ("M. hominis") fell into the group with cultivation characteristics very similar to those examined here. These workers also found that human genital PPLO could be distinguished serologically from human mouth strains, but that there was considerable cross-reaction between mouth strains and the "M. hominis" group. Dienes and Madoff (1953) also reported that human mouth and genital strains were serologically distinct. The antigenic differences found between PPLO isolated from different animal species supports the findings of Klieneberger (1938) and Warren and Sabin (1942 
